Skip to main content
SAMIL PHARMACEUTICAL CO.,LTD logo

SAMIL PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 000520 ISIN · KR7000520007 KO Manufacturing
Open in API
Filings indexed 344 across all filing types
Latest filing 2026-06-11 Director's Dealing
Country KR South Korea
Listing KO 000520

About SAMIL PHARMACEUTICAL CO.,LTD

https://www.samil-pharm.com/main/EN

Samil Pharmaceutical Co., Ltd. is a company engaged in the research, development, and manufacturing of pharmaceutical products. The company specializes in ophthalmology and also produces a diverse portfolio of drugs for other therapeutic areas, including the central nervous system (CNS), hepatic conditions, and gastrointestinal disorders. Its product range encompasses prescription medicines as well as over-the-counter remedies for common ailments like fever and colds. In addition to developing its own products, Samil Pharmaceutical offers Contract Development and Manufacturing Organization (CDMO) services to global partners. The company emphasizes research and development and collaborates with other leading pharmaceutical firms.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a regulatory disclosure titled “임원·주요주주 특정증권등 소유상황보고서” filed by an executive (임원) detailing their holdings and transactions in the company’s securities. It reports insider share ownership and changes (매수/처분) by a director, which matches the definition of Director’s Dealing (insider transactions by company directors/executives).
2026-06-11 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 90% confidence The document is a Major Event Report (‘주요사항보고서’) filed with the Financial Services Commission and the Korea Exchange, titled “Decision to Issue Convertible Bonds” for Samil Pharmaceutical Co., detailing terms of a new convertible bond issuance, conversion ratios, call/put options, fund usage, and related financing arrangements. This is a direct announcement of a financing activity (issuance of debt convertible into equity), matching the definition of a Capital/Financing Update.
2026-06-11 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 96% confidence The document is a Korean filing titled “최대주주등소유주식변동신고서” which translates to a “Report on Changes in Shareholding of Major Shareholders.” It details the numbers and percentages of shares held by the company’s major shareholders and their relatives before and after recent changes, including specific purchase transactions. This is a Major Shareholding Notification. Therefore it fits the MRQ category.
2026-06-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a Korean-language “임원ㆍ주요주주 특정증권등 소유상황보고서,” i.e. a mandatory insider holdings and transaction report filed by an officer/major shareholder to the SEC and exchange. It details personal ownership of securities, acquisition/disposition dates, quantities, and ratios. This aligns exactly with the “Director’s Dealing” category for insider share transactions (Code: DIRS).
2026-06-05 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 92% confidence The document is a ‘최대주주등 소유주식변동신고서’ – literally a report on changes in shareholding by the company’s largest shareholder and related parties. It details pre‐ and post‐transaction holdings, ownership percentages, and individual insider purchases. This matches the ‘Major Shareholding Notification’ category for changes in significant share ownership (MRQ).
2026-06-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 97% confidence The document is a report of an executive/major shareholder’s specific securities ownership and transaction (“임원ㆍ주요주주 특정증권등 소유상황보고서”), detailing share counts before and after insider trades. This matches the “Director’s Dealing” category, which covers personal share transactions by company directors and executives.
2026-06-01 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.